Microembolization is commonly associated with carotid artery stenting (CAS), but our understanding of subclinical microembolization is superficial. Through collaborative effects of multidisciplinary team-experts, novel approaches, and longitudinal evaluations, we hope to better understand the clinical significance and long-term cognitive effects of microemboli. This proposal may change our current clinical practice by providing a better outcome measure for carotid interventions and improving outcomes of CAS procedures through risk factor stratification. Our central hypothesis is that development of subclinical microemboli is associated with decline in cognitive function following CAS and that the risk of development of microemboli themselves is associated with patient- and procedure-related factors. We hope that this prospective study will help to clarify these important issues in the era of rapidly evolving percutaneous interventions.
Study Type
OBSERVATIONAL
Enrollment
207
Palo Alto Veterans Affairs
Palo Alto, California, United States
Washington University School of Medicine
St Louis, Missouri, United States
University of Wisconsin, Madison
Madison, Wisconsin, United States
Incidence of microemboli in correlation with changes in neurocognitive assessment performance
Time frame: 1 year following CAS procedure
Risk factor stratification for incidence of microemboli
Time frame: 1 year following CAS procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.